BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong S, Guo X, Han F, He Z, Wang Y. Emerging role of natural products in cancer immunotherapy. Acta Pharm Sin B 2022;12:1163-85. [PMID: 35530162 DOI: 10.1016/j.apsb.2021.08.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan Y, Xu Z, Wang J, Yu W. Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson’s disease. Front Pharmacol 2022;13:1007556. [DOI: 10.3389/fphar.2022.1007556] [Reference Citation Analysis]
2 Jian M, Sun X, Cheng G, Zhang H, Li X, Song F, Liu Z, Wang Z. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment. J Nat Prod 2022. [PMID: 36122348 DOI: 10.1021/acs.jnatprod.2c00626] [Reference Citation Analysis]
3 Yang M, Olaoba OT, Zhang C, Kimchi ET, Staveley-o’carroll KF, Li G. Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 2022;14:1630. [DOI: 10.3390/pharmaceutics14081630] [Reference Citation Analysis]
4 Thuru X, Magnez R, El-bouazzati H, Vergoten G, Quesnel B, Bailly C. Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors. Cancers 2022;14:3368. [DOI: 10.3390/cancers14143368] [Reference Citation Analysis]